Inmed Pharmaceuticals Inc.
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 15 institutions reported holding Inmed Pharmaceuticals Inc. in their 13F filings, up 1 from Q2 2024. 6 opened new positions and 5 sold out. The largest holders were AdvisorShares Investments LLC ($172K), UBS Group AG ($50K) and Citadel Advisors ($13K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Inmed Pharmaceuticals Inc.
- CUSIP
- 457637601
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $238K |
| Exits | 5 | $86K |
All 13F filers, Q2 2024 → Q3 2024: 1,085,328 shares bought and 383,617 shares sold, net +701,711 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| AdvisorShares Investments LLC | 0.03% | New | 733,296 | $172K |
| UBS Group AG | 0.00% | New | 212,039 | $50K |
| Citadel Advisors | 0.00% | Add +368.4% | 56,666 | $13K |
| Renaissance Technologies | 0.00% | New | 50,296 | $12K |
| HRT Financial LP | 0.00% | Add +139.9% | 38,369 | $8K |
| Virtu Financial LLC | 0.00% | Reduce -67.2% | 28,415 | $7K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 22,611 | $4K |
| Bank of America Corp. | 0.00% | No change | 100 | $24 |
| AllSquare Wealth Management LLC | 0.00% | No change | 21 | $5 |
| Osaic Holdings, Inc. | 0.00% | Reduce -15.6% | 27 | $5 |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 19 | $5 |
| Global Retirement Partners, LLC | 0.00% | No change | 6 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -4.0% | 24 | $0 |
| Gables Capital Management Inc. | 0.00% | No change | 1 | $0 |
| Banque Cantonale Vaudoise | 0.00% | New | 125 | $0 |
"% of holder's portfolio" is INMED PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Inmed Pharmaceuticals Inc. the manager owns.